Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W V Kern

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
International Journal of Antimicrobial Agents|October 29, 2000
Modifications of therapyW V Kern
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 1998
Epidemiology of fluoroquinolone-resistant Escherichia coli among neutropenic patientsW V Kern
International Journal of Clinical Practice|February 24, 2006
Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infectionsW V Kern
Der Internist|July 31, 2013
[Disputed therapy recommendations for infectious endocarditis]W V Kern
Der Internist|October 18, 2015
[New antibacterial agents on the market and in the pipeline]W V Kern
Drug Research|November 26, 2014
[Antibiotic stewardship - strategies for ensuring an intelligent and rational use of antibiotics]W V Kern
Therapeutische Umschau. Revue Therapeutique|January 19, 2000
[Antibiotics, new pathogens, new drug resistance]W V Kern
Current Opinion in Infectious Diseases|April 20, 2002
Risk assessment and risk-based therapeutic strategies in febrile neutropeniaW V Kern
Deutsche Medizinische Wochenschrift (1946)|September 9, 2010
[Antibiotic prescribing--who, where, what, how?]W V Kern
Deutsche Medizinische Wochenschrift (1946)|May 31, 2013
[Antibiotics in patients with fever and neutropenia]W V Kern
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
International Journal of Antimicrobial Agents|October 29, 2000
Modifications of therapyW V Kern
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 1998
Epidemiology of fluoroquinolone-resistant Escherichia coli among neutropenic patientsW V Kern
International Journal of Clinical Practice|February 24, 2006
Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infectionsW V Kern
Der Internist|July 31, 2013
[Disputed therapy recommendations for infectious endocarditis]W V Kern
Der Internist|October 18, 2015
[New antibacterial agents on the market and in the pipeline]W V Kern
Drug Research|November 26, 2014
[Antibiotic stewardship - strategies for ensuring an intelligent and rational use of antibiotics]W V Kern
Therapeutische Umschau. Revue Therapeutique|January 19, 2000
[Antibiotics, new pathogens, new drug resistance]W V Kern
Current Opinion in Infectious Diseases|April 20, 2002
Risk assessment and risk-based therapeutic strategies in febrile neutropeniaW V Kern
Deutsche Medizinische Wochenschrift (1946)|September 9, 2010
[Antibiotic prescribing--who, where, what, how?]W V Kern
Deutsche Medizinische Wochenschrift (1946)|May 31, 2013
[Antibiotics in patients with fever and neutropenia]W V Kern
Pageof 15